This creates an excess in the amount of substrates for recombination repair, which in HR-deficient cancer cells, such as BRCA1 mutated tumours, is limited to repair by lower-fidelity NHEJ, leading to chromosomal aberration such as radial chromosomes and selective death of tumour cells [88,89]. The gene discussed is BRCA1; the disease is neoplasm.